Cargando…

Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most predominant pathological subtype of lung cancer, accounting for 40–70% of all lung cancer cases. Although significant improvements have been made in the screening, diagnosis, and precise management in recent years, the prognosis of LUAD remains blea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Aimin, Liu, Na, Bai, Shuheng, Wang, Jingjing, Gao, Huan, Zheng, Xiaoqiang, Fu, Xiao, Ren, Mengdi, Zhang, Xiaoni, Tian, Tao, Ruan, Zhiping, Liang, Xuan, Yao, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947511/ https://www.ncbi.nlm.nih.gov/pubmed/33717544 http://dx.doi.org/10.21037/jtd-20-2803

Ejemplares similares

The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer
por: Jiang, Aimin, et al.
Publicado: (2020)

Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study
por: Jiang, Aimin, et al.
Publicado: (2021)

Establishment and validation of a nomogram to predict the in-hospital death risk of nosocomial infections in cancer patients
por: Jiang, Aimin, et al.
Publicado: (2022)

Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study
por: Gao, Huan, et al.
Publicado: (2021)

Prognostic Nutritional Index identifies risk of early progression and survival outcomes in Advanced Non-small Cell Lung Cancer patients treated with PD-1 inhibitors
por: Liu, Na, et al.
Publicado: (2021)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhou, Shuguang, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis
por: Chen, Xue, et al.
Publicado: (2022)

Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer
por: Cheng, Lin, et al.
Publicado: (2021)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation
por: Feng, Rui, et al.
Publicado: (2021)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Development and validation of an autophagy-related prognostic signature in esophageal cancer
por: Du, Hailei, et al.
Publicado: (2021)

Identification of Hypoxia–Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma
por: Bai, Shuheng, et al.
Publicado: (2022)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2022)

Lipid metabolism-related gene prognostic index (LMRGPI) reveals distinct prognosis and treatment patterns for patients with early-stage pulmonary adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Development and Validation of a Prognostic Index Based on Genes Participating in Autophagy in Patients With Lung Adenocarcinoma
por: Wu, Zi-Xuan, et al.
Publicado: (2022)

Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer
por: Wu, Qianxue, et al.
Publicado: (2021)

Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma
por: Park, Yun-Yong, et al.
Publicado: (2012)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
por: Jiang, Aimin, et al.
Publicado: (2022)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

Identification of an eight-gene prognostic signature for lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
por: Zheng, Lian, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model
por: Wu, Liusheng, et al.
Publicado: (2021)

A Five Autophagy-Related Long Non-Coding RNA Prognostic Model for Patients with Lung Adenocarcinoma
por: Liu, Boxuan, et al.
Publicado: (2021)

Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy
por: Zhong, Shanliang, et al.
Publicado: (2020)

Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma
por: Fang, Jiayu, et al.
Publicado: (2021)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Developing and Validating an Autophagy Gene-Set-Based Prognostic Signature in Hepatocellular Carcinoma Patients
por: Zhang, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_10mcpjv54keucel4o1cd21ddh7